Biotronik Neurovascular
>> Saturday, January 2, 2010
Biotronik, a leading European company in the field of biomedical technology, develops and markets a line of neuroendovascular devices that includes guidewires, balloon catheters as well as stents.
In January 2006, Biotronik entered into a license, development and distribution agreement with Micrus Endovascular to provide Micrus with exclusive access to certain stent technologies for neurovascular applications which covers the PHAROS stent that received CE Mark authorization in February 2006 for both cerebral aneurysms and ischemic disease.
In January 2006, Biotronik entered into a license, development and distribution agreement with Micrus Endovascular to provide Micrus with exclusive access to certain stent technologies for neurovascular applications which covers the PHAROS stent that received CE Mark authorization in February 2006 for both cerebral aneurysms and ischemic disease.
0 comments:
Post a Comment